Adding Journey Medical (DERM) to the MCO Portfolio

Paid subscriber alert

For our paid subscribers we issue this alert. We are adding DERM to our MCO portfolio at today’s closing price of $7.70. I expect we will write more extensively about it in the future. Thank you for your continued support!

✅ Overview

• Emrosi was approved by the U.S. FDA in November 2024 for the treatment of papules and pustules associated with rosacea in a…